# A Study to Learn How Different Forms of the Study Medicine Called PF-08049820 Are Absorbed and Eliminated in Healthy Adults

> **NCT07597928** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 24 (actual)

## Conditions studied

- Healthy Adults
- Healthy

## Interventions

- **DRUG:** PF-08049820
- **DRUG:** Rabeprazole

## Key facts

- **NCT ID:** NCT07597928
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2026-05-13
- **Primary completion:** 2026-08-07
- **Final completion:** 2026-09-01
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2026-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07597928

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07597928, "A Study to Learn How Different Forms of the Study Medicine Called PF-08049820 Are Absorbed and Eliminated in Healthy Adults". Retrieved via MORVS 2026-11-22 from https://api.morvs.ai/clinical/NCT07597928. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
